TIMP3 and early-onset autosomal dominant Alzheimer disease: Molecular analysis and studies of their downstream functional consequences may help elucidate the shared pathophysiological mechanisms in these diseases, potentially leading to the development of novel therapies for diseases in which TIMP3 accumulation has also been observed—these include more severe forms of AMD, and through indirect mechanisms, Alzheimer’s disease [28,29].